Jakarta, Oct. 13 -- The Indonesian Food and Drug Authority (BPOM) has partnered with 187 top domestic universities to boost the advanced therapy medicinal products (ATMP) ecosystem through research, innovation, and commercialization.

BPOM head Taruna Ikrar highlighted the move in Jakarta on Tuesday during the signing of a joint commitment with several institutions, including the Ministry of Health and the Ministry of Higher Education, Science, and Technology, to develop the country's stem cell therapy ecosystem.

Ikrar explained that Indonesia has so far authorized only one type of ATMP, which is still imported. By comparison, the US Food and Drug Administration (FDA) has approved 48 ATMP products, while Japan has authorized around 26. ...